FISHER SCIENTIFIC CHEMICAL -- MANGANOUS SULFATE MONOHYDRATE, M113 ======================================================= MSDS Safety Information ======================================================= FSC: 6810 MSDS Date: 07/31/1992 MSDS Num: CBCBB LIIN: 00N037634 Product ID: MANGANOUS SULFATE MONOHYDRATE, M113 MFN: 02 Responsible Party Cage: 1B464 Name: FISHER SCIENTIFIC CHEMICAL Address: 1 REAGENT LN City: FAIR LAWN NJ 07410 Info Phone Number: 201-796-7100 Emergency Phone Number: 800-424-9300 (CHEMTREC) Published: Y ======================================================= Contractor Summary ======================================================= Cage: 1B464 Name: FISHER SCIENTIFIC CO. CHEMICAL MFG DIV Address: 1 REAGENT LANE City: FAIR LAWN NJ 07410-2802 Phone: 201-796-7100 ======================================================= Ingredients ======================================================= Name: ING 11: 50 MG/KG/DAY. DAILY URINALYSES SHOULD BE DONE DURING TREATMENT PERIOD. DOSE SHOULD BE REDUCED IF ANY ----------------------------- Name: ING 12:UNUSUAL URINARY FINDINGS APPEAR. IV ADMIN IS CONTRAINDICATED IN PRESENCE OF ELEVATED CEREBROSPINAL FLUID ----------------------------- Name: ING 13: PRESS. FOR INTRAMUSC ADMIN, GIVE 20% SOLN (200MG/ML), 12.5MG/KG BODY WT EVERY 4-6 HRS. DILUTE EACH DOSE ----------------------------- Name: ING 14:W/EQUAL VOL OF 1% PROCAINE. DOSE LIMIT IS SAME AS GIVEN ABOVE. ANTIDOTE SHOULD BE ADMIN BY QUALIFIED MED PERS. ----------------------------- Name: SPILL PROC: ABSORB MATL & PLACE INTO CNTNRS FOR LATER DISP. FOR LG SPILLS, DIKE FAR AHEAD OF SPILL FOR LATER ----------------------------- Name: ING 16: DISPOSAL. KEEP UNNEC PEOPLE AWAY. ISOLATE HAZARD AREA & DENY ENTRY. ----------------------------- Name: RESP PROT:PARTICULATE RESP. SUPPLIED-AIR RESP. SCBA. 250 MG(MN)/M3- HIGH-EFFICIENCY PARTICULATE RESP. SUPPLIED- ----------------------------- Name: ING 18:AIR RESP W/FULL FACEPIECE, HELMET OR HOOD. SCBA W/FULL FACEPIECE. 500 MG(MN)/M3- POWERED AIR-PURIFYING ----------------------------- Name: ING 19: RESP W/HIGH-EFFICIENCY FILTER. TYPE C SUPPLIED-AIR RESP OPERATED IN PRESS-DEMAND OR OTHER POS PRESS OR ----------------------------- Name: ING 20: CONTINUOUS-FLOW MODE. 10,000 MG(MN)/M3- TYPE C SUPPLIED-AIR RESP W/FULL FACEPIECE OPERATED IN PRESS- ----------------------------- Name: ING 21: DEMAND OR OTHER POS PRESS MODE OR WITH FULL FACEPIECE, HELMET OR HOOD OPERATED IN CONTINUOUS-FLOW MODE. ----------------------------- Name: EYE PROT: & FULL LENGTH FACESHIELD (FP N). ----------------------------- Cas: 10034-96-5 RTECS #: OP0893500 Name: MANGANESE, MONOSULFATE, MONOHYDRATE; (MANGANOUS SULFATE MONOHYDRATE) % Wt: 100 OSHA PEL: 5 MG MN/M3 CEILING ACGIH TLV: 5 MG MN/M3 ------------------------------ Name: SUPDAT: COUNTS & INCRD OSMOTIC FRAGILITY OF BLOOD. INGEST: MAY CAUSE SYMPS SIMILAR TO INHAL EFTS INCL SEV CNS DISTURBS. ----------------------------- Name: FIRST AID: ATTN IMMED. EYES:WASH IMMED W/LG AMTS OF WATER/NORM SALINE, OCCAS LIFTING UPPER & LOWER LIDS UNTIL NO ----------------------------- Name: ING 3: EVID OF CHEM REMAINS (AT LEAST 15-20 MIN). GET MED ATTN IMMED. INGEST:TREAT SYMP & SUPPORTIVELY. GET MED ----------------------------- Name: ING 4: ATTN IMMED. IF VOMIT OCCURS, KEEP HEAD LOWER THAN HIPS TO PVNT ASPIR. FOLLOWING ANTIDOTE RECOM, HOWEVER, ----------------------------- Name: ING 5: DECISION IF SEVERITY OF POIS REQS ADMIN OF ANTIDOTE & ACTUAL DOSE REQD SHOULD BE MADE BY QUALIFIED MED ----------------------------- Name: ING 6: PERS. CALCIUM EDETATE IS EFTIVE IN REMOVING MANGANESE BUT HAS NO PERM EFT ON SYMPTOMATIC PATIENTS IN LATE ----------------------------- Name: ING 7: STAGES OF MANGANISM. ADMIN OF CALCIUM DISODIUM EDETATE IS RECOM. EDETATE IS AVAIL AS 5 ML AMPULES OF 20% ----------------------------- Name: ING 8: SOLN. GIVE 15-25 MG/KG (0.80-0.125 ML OF 20% SOLN/KG BODY WT) IN 250-500ML OF 5% DEXTROSE IV OVER 1 TO 2 ----------------------------- Name: ING 9:HR PERIOD TWICE DAILY. MAX DOSE SHOULD NOT EXCEED 50MG/KG/DAY. DRUG SHOULD BE GIVEN IN 5-DAY COURSES WITH ----------------------------- Name: ING 10: REST PERIOD OF @ LEAST 2 DAYS BETWEEN COURSES. AFTER FIRST COURSE, SUBSEQUENT COURSES SHOULD NOT EXCEED ======================================================= Health Hazards Data ======================================================= LD50 LC50 Mixture: NONE SPECIFIED BY MANUFACTURER. Route Of Entry Inds - Inhalation: YES Skin: YES Ingestion: YES Carcinogenicity Inds - NTP: NO IARC: NO OSHA: NO Effects of Exposure: ACUTE: INHAL:10,000PPM (MN) IMMED DANGEROUS TO LIFE/HLTH. MAY CAUSE COUGH, CHOKING & TRACHEAL IRRIT. SKIN:NO DATA AVAIL; MAY CAUSE IRRIT. EYES:DIRECT CNTCT MAY CAUSE IRRIT & LACRIM. INGEST:MANGANESE S ALTS ARE POORLY ABSORBED BUT MAY CAUSE GASTRITIS, NAUS, DIARR & HYPOGLYCEMIA. CHRONIC:MAY CAUSE HDCH, (EFTS OF OVEREXP) Explanation Of Carcinogenicity: NOT RELEVANT Signs And Symptions Of Overexposure: HLTH HAZ:RESTLESS SLEEP, DROW, IRRITABILITY, DIZZ, HYPOTENSION, PATHOLOGIC LAUGHTER/GIDD, CONVLS, VISUAL HALLUCINATIONS, DOUBLE VISION, IMPAIRED HEARING, UNCONTROLABLE IMPULSES, MENTAL CONFUSN, EUPHOR IA, EXCESS SALIVATION, CHILLS, FEVER, ACHING MUSCS, MOUTH & THROAT DRYNESS, BRONCH & PNEUM & IMPOTENCE. AFTER (SUPDAT) Medical Cond Aggravated By Exposure: NONE SPECIFIED BY MANUFACTURER. First Aid: INHAL:REMOVE TO FRESH AIR IMMED. IF BRTHG HAS STOPPED, PERFORM ARTF RESP. KEEP WARM & @ REST. TREAT SYMP & SUPPORTIVELY. GET MED ATTN IMMED. SKIN:REMOVE CONTAMD CLTHG & SHOES IMMED. WASH AREA W/SOAP O R MILD DETERGENT & LG AMTS OF WATER UNTIL NO EVID OF CHEM REMAINS (AT LEAST 15-20 MIN). IN CASE OF CHEM BURNS, COVER W/STERILE, DRY DRESSING. BANDAGE SECURELY BUT NOT TOO TIGHTLY. GET MED ======================================================= Handling and Disposal ======================================================= Spill Release Procedures: KEEP COMBUSTS (WOOD, PAPER, OIL, ETC) AWAY FROM SPILLED MATL. DO NOT TOUCH SPILLED MATL. FOR SM DRY SPILLS W/CLEAN SHOVEL PLACE MATL INTO CLEAN, DRY CNTNR & COVER; MOVE CNTNRS FROM SPILL AREA. FOR SM LIQ SPILLS, TAKE UP W/SAND, EARTH/OTHER Neutralizing Agent: NONE SPECIFIED BY MANUFACTURER. Waste Disposal Methods: DISPOSAL MUST BE IN ACCORDANCE WITH FEDERAL, STATE AND LOCAL REGULATIONS (FP N). Handling And Storage Precautions: NONE SPECIFIED BY MANUFACTURER. Other Precautions: NONE SPECIFIED BY MANUFACTURER. ======================================================= Fire and Explosion Hazard Information ======================================================= Extinguishing Media: DRY CHEMICAL, CARBON DIOXIDE, WATER SPRAY OR REGULAR FOAM. FOR LARGER FIRES, USE WATER SPRAY, FOG OR REGULAR FOAM. Fire Fighting Procedures: USE NIOSH/MSHA APPRVD SCBA & FULL PROTECTIVE EQUIPMENT (FP N). NO ACUTE HAZARD. MOVE CNTNR FROM FIRE AREA IF POSSIBLE. AVOID BRTHG VAPS/DUST; KEEP UPWIND. Unusual Fire/Explosion Hazard: NEGLIGIBLE FIRE HAZARD WHEN EXPOSED TO HEAT OR FLAME. ======================================================= Control Measures ======================================================= Respiratory Protection: USE NIOSH/MSHA APPRVD RESPS (FP N). AS DUST/MIST: 25 MG(MN)/M3- DUST & MIST RESPS, EXCEPT SINGLE USE. 50 MG(MN)/M3- DUST & MIST RESPS, EXCEPT SINUE USE & QUARTER-MASK RESPS. AS DUST, MIST/FUME: 50 MG( MN)/M3- FUME OR HIGH-EFFICIENCY Ventilation: PROVIDE LOCAL EXHAUST VENTILATION AND/OR GENERAL DILUTION VENTILATION TO MEET PUBLISHED EXPOSURE LIMITS. Protective Gloves: IMPERVIOUS GLOVES (FP N). Eye Protection: ANSI APPRVD CHEM WORKERS GOGGS Other Protective Equipment: ANSI APPROVED EYE WASH & DELUGE SHOWER (FP N). APPROP PROT (IMPERVIOUS) CLTHG & EQUP TO PVNT POSSIBILITY OF SKIN CNTCT. Work Hygienic Practices: NONE SPECIFIED BY MANUFACTURER. Supplemental Safety and Health: EFTS OF OVEREXP: PRLNGD PERIOD OF TIME, SYMPS OF PARKINSONS' DISEASE MAY APPEAR; INCLS MASK-LIKE FACIAL EXPRESSIONS, MUSC WEAK & RIGIDITY, SALIVATION, TREMORS OF UPPER EXTREMS & HEAD, STAG & SLURRED S PEECH. MAY ALSO CAUSE LIVER, KIDNEY & PERM BRAIN DMG. OTHER SYMPS MAY INCL LEUCOPENIA, ELEVATED ERYTHROCYTE ======================================================= Physical/Chemical Properties ======================================================= M.P/F.P Text: 135F,57C Spec Gravity: 2.9 Appearance and Odor: PALE RED, SLIGHTLY EFFLORESCENT CRYSTALS. ======================================================= Reactivity Data ======================================================= Stability Indicator: YES Stability Condition To Avoid: STABLE UNDER NORMAL TEMPERATURES AND PRESSURES. AVOID HEATING TO DECOMPOSITION. Materials To Avoid: NONE KNOWN. Hazardous Decomposition Products: THERMAL DECOMPOSITION MAY RELEASE TOXIC OXIDES OF SULFUR. Hazardous Polymerization Indicator: NO Conditions To Avoid Polymerization: NOT RELEVANT ======================================================= Toxicological Information ======================================================= ======================================================= Ecological Information ======================================================= ======================================================= MSDS Transport Information ======================================================= ======================================================= Regulatory Information ======================================================= ======================================================= Other Information ======================================================= ======================================================= HAZCOM Label ======================================================= Product ID: MANGANOUS SULFATE MONOHYDRATE, M113 Cage: 1B464 Company Name: FISHER SCIENTIFIC CO. CHEMICAL MFG DIV Street: 1 REAGENT LANE City: FAIR LAWN NJ Zipcode: 07410-2802 Health Emergency Phone: 800-424-9300 (CHEMTREC) Label Required IND: Y Date Of Label Review: 05/03/1996 Status Code: C Label Date: 05/03/1996 Origination Code: G Chronic Hazard IND: Y Eye Protection IND: YES Skin Protection IND: YES Signal Word: DANGER Respiratory Protection IND: YES Health Hazard: Severe Contact Hazard: Moderate Fire Hazard: None Reactivity Hazard: Slight Hazard And Precautions: DECOMPOSITION PRODUCTS MAY BE TOXIC. ACUTE: INHALATION: COUGH, CHOKING AND TRACHEAL IRRITATION. SKIN: IRRITATION. EYES: IRRITATION AND LACRIMATION. INGESTION: GASTRITIS, NAUSEA, DIARRHEA AND HYPOGLYCE MIA. CHRONIC: HEADACHE, RESTLESS SLEEP,DROWSINESS, IRRITABILITY, DIZZINESS, HYPOTENSION, GIDDINESS, CONVULSIONS, HALLUCINATIONS, DOUBLE VISION, IMPAIRED HEARING, UNCONTROLABLE IMPULSES, CONFUSION, EUP HORIA, SALIVATION, CHILLS, FEVER, ACHING MOUTH AND THROAT DRYNESS, BRONCHITIS,PNEUMONIA AND IMPOTENCE. PARKINSON'S DISEASE LIKE SYMPTOMS. LIVER, KIDNEY AND BRAIN DAMAGE. ======================================================= Disclaimer (provided with this information by the compiling agencies): This information is formulated for use by elements of the Department of Defense. The United States of America in no manner whatsoever expressly or implied warrants, states, or intends said information to have any application, use or viability by or to any person or persons outside the Department of Defense nor any person or persons contracting with any instrumentality of the United States of America and disclaims all liability for such use. Any person utilizing this instruction who is not a military or civilian employee of the United States of America should seek competent professional advice to verify and assume responsibility for the suitability of this information to their particular situation regardless of similarity to a corresponding Department of Defense or other government situation.